Hertogs; Kurt

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hertogs; Kurt.The latest application filed is for "substituted indolepyridinium as anti-infective compounds".

Company Profile

0.12.17

Hertogs; Kurt - Antwerpen N/A BE
Hertogs; Kurt - Antwerp BE
Hertogs; Kurt - Nieuwpoort BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance Grant 8,574,831 - Dehertogh , et al. November 5, 2	2013-11-05
Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance Grant 8,563,236 - Hertogs , et al. October 22, 2	2013-10-22
Substituted Indolepyridinium As Anti-infective Compounds App 20100048563 - KESTELEYN; Bart Rudolf Romanie ; et al.	2010-02-25
Substituted indolepyridinium as anti-infective compounds Grant 7,608,726 - Kesteleyn , et al. October 27, 2	2009-10-27
HIV replication inhibiting pyrimidines and triazines Grant 7,585,870 - Guillemont , et al. September 8, 2	2009-09-08
Mutational Profiles In Hiv-1 Reverse Transcriptase Correlated With Phenotypic Drug Resistance App 20090162867 - Hertogs; Kurt ; et al.	2009-06-25
Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance Grant 7,494,768 - Hertogs , et al. February 24, 2	2009-02-24
Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance App 20080286754 - DEHERTOGH; Pascale Alfons Rosa ; et al.	2008-11-20
HIV replication inhibiting pyrimidines and triazines Grant 7,442,705 - Guillemont , et al. October 28, 2	2008-10-28
Small molecule entry inhibitors Grant 7,429,677 - De Bethune , et al. September 30, 2	2008-09-30
Hcv Inhibiting Sulfonamides App 20080234288 - Simmen; Kenneth Alan ; et al.	2008-09-25
Establishment of biological cut-off values for predicting resistance to therapy Grant 7,292,944 - Larder , et al. November 6, 2	2007-11-06
4-Substituted-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones App 20070249655 - Kesteleyn; Bart Rudolf Romanie ; et al.	2007-10-25
Methods for Measuring Therapy Resistance App 20070166747 - Larder; Brendan ; et al.	2007-07-19
Methods for measuring therapy resistance Grant 7,206,699 - Larder , et al. April 17, 2	2007-04-17
Time-of-addition assay for identifying anti-viral compounds App 20060286547 - Van Acker; Koenraad Lodewidjk August ; et al.	2006-12-21
Hiv replication inhibiting pyrimidines and triazines App 20060194804 - Guillemont; Jerome Emile Georges ; et al.	2006-08-31
Substituted indolepyridinium as anti-infective compounds App 20060173000 - Kesteleyn; Bart Rudolf Romanie ; et al.	2006-08-03
Hiv replication inhibiting pyrimidines and triazines App 20060142571 - Guillemont; Jerome Emile Georges ; et al.	2006-06-29
Small molecule entry inhibitors App 20060025594 - De Bethune; Marie-Pierre T.M.M.G ; et al.	2006-02-02
Method for measuring drug resistance App 20040137436 - Larder, Brendan ; et al.	2004-07-15
Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance App 20040073378 - Dehertogh, Pascale Alfons Rosa ; et al.	2004-04-15
Establishment of biological cut-off values for predicting resistance to therapy App 20040033489 - Larder, Brendan ; et al.	2004-02-19
Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains App 20030152917 - de Bethune, Marie-Pierre ; et al.	2003-08-14
Methods for measuring therapy resistance App 20020091664 - Larder, Brendan ; et al.	2002-07-11
Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains App 20020042679 - de Bethune, Marie-Pierre ; et al.	2002-04-11
Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains Grant 6,221,578 - de Bethune , et al. April 24, 2	2001-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.